Literature DB >> 1646840

Model for studying virus attachment. II. Binding of biotinylated human T cell leukemia virus type I to human blood mononuclear cells potential targets for human T cell leukemia virus type I infection.

S Dhawan1, H Z Streicher, L M Wahl, N Miller, A T Louie, I S Goldfarb, W L Jackson, P Casali, A L Notkins.   

Abstract

Purified human T cell leukemia virus type I (HTLV-I) was biotinylated and used to study its attachment to human PBMC. The use of biotinylated HTLV-I (biot-HTLV-I) in conjunction with mouse mAb specific for selected cell-surface molecules and flow cytometric analysis allowed us to positively identify virus-binding cells among a heterogeneous blood mononuclear cell population. Biot-HTLV-I efficiently bound not only to T cells, but also to B cells and monocytes. Preincubation of monocytes with excess of unlabeled HTLV-I significantly reduced the attachment of biot-HTLV-I. HTLV-I not only bound to, but also infected, B cells, as suggested by: i) in situ hybridization of a 35S-labeled full length HTLV-I DNA probe with EBV-transformed B cells, previously cocultured with HTLV-I-producing (G11MJ) T cells, and ii) hybridization of the same nick-translated 32P-labeled DNA probe with blotted DNA from similar HTLV-I-infected EBV-transformed B cells. HTLV-I infection did not affect the ability of B cells to secrete IgG. These findings suggest that HTLV-I cannot only infect cells of the T lineage, but can also infect B cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1646840

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  A novel high throughput quantum dot-based fluorescence assay for quantitation of virus binding and attachment.

Authors:  Karan Kampani; Kevin Quann; Jaya Ahuja; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Virol Methods       Date:  2007-01-03       Impact factor: 2.014

Review 2.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 3.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

4.  Human T-cell lymphotropic virus type 1 (HTLV-1)-induced syncytium formation mediated by vascular cell adhesion molecule-1: evidence for involvement of cell adhesion molecules in HTLV-1 biology.

Authors:  J E Hildreth; A Subramanium; R A Hampton
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

5.  Baboon T cell lymphomas expressing the B cell-associated surface proteins CD40 and Bgp95.

Authors:  L V Indzhiia; L A Yakovleva; J Overbaugh; K A Licciardi; M G Chikobava; I N Klotz; R Torres; V O Indzhiia; B A Lapin; E A Clark
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

6.  Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

Authors:  J Lisziewicz; D Sun; J Smythe; P Lusso; F Lori; A Louie; P Markham; J Rossi; M Reitz; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

7.  Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

Authors:  P M Hoffman; S Dhib-Jalbut; J A Mikovits; D S Robbins; A L Wolf; G K Bergey; N C Lohrey; O S Weislow; F W Ruscetti
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.

Authors:  J E Hildreth
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Use of FITC-labeled influenza virus and flow cytometry to assess binding and internalization of virus by monocytes-macrophages and lymphocytes.

Authors:  J E Nichols; D J Mock; N J Roberts
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.